Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 705 results for "ranbaxy industries"

Sun Pharma up 3%, raises Ranbaxy's products prices in US

Shares of Sun Pharmaceutical Industries gained 2.8 percent intraday Tuesday. Brokerage Credit Suisse said the drug maker has taken price increases in six of Ranbaxy's branded products in the US in May 2015. On an annualised basis, price increases ..., 1 day ago
Sun Pharma shares seen rising Hindu Business Line, 1 month ago

35 images for ranbaxy industries

DNA, 1 week ago
NDTV Profit, 1 month ago
Business Today India, 1 month ago
Reuters, 1 month ago
India Infoline, 4 weeks ago, 1 month ago
Reuters, 2 months ago, 1 month ago
The Fiscal Times, 2 months ago
Business Insider, 2 months ago

Post merger: Sun Pharma asks some Ranbaxy workmen to leave

Friday, 19 June 2015 | PTI | New Delhi Sun Pharmaceutical Industries has started easing out excess employees from Ranbaxy, including senior executives, following completion of its $4 billion acquisition of the Gurgaon-based firm.When asked to ...
 New Delhi Pioneer1 week ago Ranbaxy exec shown the door  News Today1 week ago Sun Pharma asks some Ranbaxy employees to leave, post merger  Business Standard1 week ago Top executives in Ranbaxy shown the door as Sun Pharma takes charge  DNA1 week ago
India Infoline

Important to re-establish trust between Ranbaxy and USFDA: Sun Pharma

An employee speaks on phone as he walks out of research and development centre of Sun Pharmaceutical Industries Ltd in Mumbai Sun Pharma will focus on one plant at a time as it looks to make four manufacturing units of Ranbaxy, which have been ...
 Business Standard India3 weeks ago Sun Pharma ask 18 top executives of Ranbaxy Labs to resign  India Infoline1 week ago Sun Pharma sacks 18 top ex-Ranbaxy executives  Money Today1 week ago Sun Pharma aims USD 250 mn synergy in 3 years post Ranbaxy integration: Uday Baldota  India Infoline4 weeks ago

Sun Pharma tanks 10% on dismal Q4; Ranbaxy merger seen hurting in short term

Shares of Sun Pharmaceutical Industries tanked nearly 10 percent in early Monday trade, weighed down by lower-than-expected fourth quarter earnings announced Friday as investors reduced their exposure fearing more downside amid sluggish broad market ...
 Firstpost.com4 weeks ago Sun Pharma shares tank 10% on Q4 results  Hindu Business Line1 month ago BUZZ-India's Sun Pharma slumps as much as 10 pct on Q4 results  Reuters India1 month ago Sun Pharma slumps as much as 10 pct on Q4 results  Sify4 weeks ago

Sun Pharma-Ranbaxy: honeymoon over, now to make it work

New Delhi, June 1 -- The first financial results of Sun Pharmaceutical Industries Ltd and Ranbaxy Laboratories Ltd after they became one is likely to leave the market puzzled. The Street may even push down its share a notch or two after seeing the ...
 HT Syndication4 weeks ago Sun Pharma-Ranbaxy merger: honeymoon over, now to make it work  Livemint.com4 weeks ago
India Infoline

Sun Pharma drops after listing of shares allotted to Ranbaxy shareholders

Capital Market April 17, 2015 Last Updated at 10:56 IST Sun Pharmaceutical Industries fell 1.64% to Rs 1,071.70 at 11:04 IST on BSE after shares allotted to shareholders of Ranbaxy Laboratories on merger were admitted for trading on the bourses today, 17 ...
 Business Standard2 months ago Sun Pharma Board approves allotment of 33.49 Cr equity shares to Ranbaxy Shareholders  India Infoline2 months ago Sun Pharma: Updates on allotment of equity shares and NCDs  Money Control2 months ago Sun Pharma spurts 3% after allotment of shares  India Infoline2 months ago
India Infoline

Daiichi Sankyo to sell stake in Sun Pharma

Sankyo will sell part or all of its holding in Sun Pharmaceutical Industries which its received following the merger of Ranbaxy into the Indian pharma major. Daiichi Sankyo said it would not be a major shareholder in Sun Pharma although its existing business ...
 Business Standard2 months ago Sun Pharma slumps 9% on Daiichi exit  India Infoline2 months ago Daiichi Sankyo plans to sell 9% stake in Sun Pharma  India Infoline2 months ago Daiichi Sankyo Sells Shares Of Sun Pharma  Asian Scientist1 month ago

Sun and Ranbaxy marriage puts Sun founder Shanghvi in position to influence industry

Sun Pharma Managing Director Dilip Shanghvi The combo of Sun Pharmaceutical and Ranbaxy Laboratories just weeks ago created a significant force in the global generics market by any number of measures. It is India 's largest drugmaker by far and ...
 FiercePharmaManufacturing1 month ago
Business Today India

Stocks in news: Nestle India, Deep Industries

Marksans Pharma: Shares surged 8.43 per cent after the company acquired US-based Time-Cap Laboratories for an undisclosed amount. With this move, Marksans is strategically increasing its presence in the US market, the largest pharmaceutical market ...
 Business Today India1 day ago

Pharma's struggle to cope standards paves way for MA deals

I Two years after its most high-profile regulatory setback to date in the United States - Ranbaxy 's USD 500 million US fine for drug safety violations - India's USD 15 billion a year generic drug industry is still rebuilding its image in its ...
 Moneycontrol.com2 days ago Pharma Industry's Struggle to Tighten Standards Paves Way for M&A Deals  NDTV Profit1 day ago Pharma Industries' Struggle to Tighten Standards Paves Way for M&A Deals  NDTV Profit2 days ago Pharma industry's struggles to tighten standards paves way for M&A deals  Economic Times2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less